Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-07-31

Clinical Trial Update: Study for Evaluating the Real Use of Inhaled Aztreonam Lysine in Patients With Cystic Fibrosis

View source ↗

Summary

Clinical trial update evaluating the real-world use of inhaled aztreonam lysine in cystic fibrosis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aztreonam lysine inhalation solution (Aztreonam lysine)

Snippet

Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: Cystic Fibrosis | Status: UNKNOWN